<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7418</journal-id>
<journal-title><![CDATA[Revista Colombiana de Ciencias Químico - Farmacéuticas]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. colomb. cienc. quim. farm.]]></abbrev-journal-title>
<issn>0034-7418</issn>
<publisher>
<publisher-name><![CDATA[Departamento de Farmácia, Facultad de Ciencias, Universidade Nacional da Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-74182019000200396</article-id>
<article-id pub-id-type="doi">10.15446/rcciquifa.v48n2.82717</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Analysis of the reports sent to an institutional patient safety program]]></article-title>
<article-title xml:lang="es"><![CDATA[Análisis de los reportes enviados a un programa institucional de seguridad de pacientes]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cortázar]]></surname>
<given-names><![CDATA[Yira Constanza]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Orozco]]></surname>
<given-names><![CDATA[José Gilberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[José Julián]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional de Colombia Departament of Pharmacy ]]></institution>
<addr-line><![CDATA[Bogotá D. C.]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional de Colombia Faculty of Medicine ]]></institution>
<addr-line><![CDATA[Bogotá D. C.]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2019</year>
</pub-date>
<volume>48</volume>
<numero>2</numero>
<fpage>396</fpage>
<lpage>410</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0034-74182019000200396&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0034-74182019000200396&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0034-74182019000200396&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  Introduction: Pharmacovigilance and patient safety programs have in common the monitoring of drugs, but despite sharing epidemiological method, language and legislation, there does not seem to be a clear relationship between them.  Objectives: Characterize and analyze the reports sent to the institutional patient safety program.  Materials and methods: Observational descriptive cross-sectional study of the reports database from an institutional patient safety program during 2016. Medication errors were classified according to the document WHO 2009. Adverse Drugs Reactions (ADR) were classified according to Uppsala Monitoring Center.  Results: From the patient safety program it was detected that the omission of drugs or doses was the most frequent error (42.8%) followed by ADRs (20.9%). Harmful incidents were the most frequent (61.2%) followed by no harm incidents (38.8%). From the pharmacovigilance program 41 ADR and 15 therapeutic failures were identified, in which Phlebitis was the most frequently reported (23, 7%) followed by hypersensitivity reactions (18.4%) and excessive neuromuscular blockade (13.1%).  Conclusions: A very important amount of incidents is not considered by any of the two programs, losing a valuable risk management opportunity. The program did not identify a clear distinction between harmful incident and ADR.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: Los programas de farmacovigilancia y seguridad de pacientes tienen en común la vigilancia de los medicamentos, pero a pesar de compartir método epidemiológico, lenguaje y legislación, no parece existir una clara articulación entre ellos.  Objetivos: Caracterizar y analizar los reportes enviados al programa institucional de seguridad de pacientes.  Materiales y métodos: Estudio observacional descriptivo de corte transversal de la base de datos de reportes de un programa de seguridad de pacientes durante el 2016. Los errores de medicación se clasificaron según el documento OMS del 2009. Las reacciones adversas (RAM) se clasificaron de acuerdo con el Uppsala Monitoring Center.  Resultados: Desde el programa de seguridad de paciente se detectó que la omisión de medicamentos o dosis fue el error más frecuente (42,8%) seguido por las RAM (20,9%). Los incidentes con daños fueron los más frecuentes (61,2%) seguidos por los incidentes sin daño (38,8%). Desde el programa de farmacovigilancia se identificaron 41 RAM y 15 fallos terapéuticos siendo la flebitis las más frecuentemente reportadas (23,7%) seguidas de las reacciones de hipersensibilidad (18,4%) y el bloqueo neuromuscular excesivo (13,1%).  Conclusiones: Una proporción importante de incidentes no es tenida en cuenta por ninguno de los dos programas, perdiéndose una valiosa oportunidad de gestión del riesgo. En el programa no se identificó una clara distinción entre incidente con daño y RAM.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Pharmacovigilance]]></kwd>
<kwd lng="en"><![CDATA[patient safety]]></kwd>
<kwd lng="en"><![CDATA[adverse drug reactions]]></kwd>
<kwd lng="en"><![CDATA[medication errors]]></kwd>
<kwd lng="es"><![CDATA[Farmacovigilancia]]></kwd>
<kwd lng="es"><![CDATA[seguridad del paciente]]></kwd>
<kwd lng="es"><![CDATA[reacciones adversas relacionados con medicamentos]]></kwd>
<kwd lng="es"><![CDATA[errores de medicación]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Routledge]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[150 years of pharmacovigilance]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1998</year>
<volume>351</volume>
<numero>1200</numero>
<issue>1200</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strom]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[What is Pharmacoepidemiology?]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Strom]]></surname>
<given-names><![CDATA[B.L.]]></given-names>
</name>
<name>
<surname><![CDATA[Hennessy]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Pharmacoepidemiology]]></source>
<year>2012</year>
<edition>5</edition>
<publisher-loc><![CDATA[Ltd., Chichester, UK ]]></publisher-loc>
<publisher-name><![CDATA[John Wiley &amp; Sons]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Talley]]></surname>
<given-names><![CDATA[R.B.]]></given-names>
</name>
<name>
<surname><![CDATA[Laventurier]]></surname>
<given-names><![CDATA[M.F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug-induced illness]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1974</year>
<volume>229</volume>
<numero>1043</numero>
<issue>1043</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manasse]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication use in an imperfect world: Drug misadventuring as an issue of public policy, Part 1]]></article-title>
<source><![CDATA[Am. J. Hosp. Pharm]]></source>
<year>1989</year>
<volume>46</volume>
<numero>929</numero>
<issue>929</issue>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manasse]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication use in an imperfect world: Drug misadventuring as an issue of public policy, Part 2]]></article-title>
<source><![CDATA[Am. J. Hosp. Pharm]]></source>
<year>1989</year>
<volume>46</volume>
<numero>1141</numero>
<issue>1141</issue>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lazarou]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pomeranz]]></surname>
<given-names><![CDATA[B.H.]]></given-names>
</name>
<name>
<surname><![CDATA[Corey]]></surname>
<given-names><![CDATA[P.N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1998</year>
<volume>279</volume>
<numero>1200</numero>
<issue>1200</issue>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>Organizacion Panamericana de la Salud</collab>
<source><![CDATA[Buenas prácticas de farmacovigilancia]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Washington, D. C ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Angulo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Valcárcel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vaca]]></surname>
<given-names><![CDATA[C.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Orozco]]></surname>
<given-names><![CDATA[J.G.]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[JJ.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conceptos básicos en farmacovigilancia]]></article-title>
<source><![CDATA[Boletín de Farmacovigilancia]]></source>
<year>2006</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Angulo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Valcárcel]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vaca]]></surname>
<given-names><![CDATA[C.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Orozco]]></surname>
<given-names><![CDATA[J.G.]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[J.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conceptos básicos en farmacovigilancia 1]]></article-title>
<source><![CDATA[Boletín de Farmacovigilancia]]></source>
<year>2006</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baciu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Stratton]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[The future of drug safety: promoting and protecting the health of the public]]></source>
<year>2006</year>
<publisher-name><![CDATA[Committee on the Assessment of the US Drug Safety System]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aranaz]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Aibar]]></surname>
<given-names><![CDATA[R.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Vitaller]]></surname>
<given-names><![CDATA[B.J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Estudio nacional sobre los efectos adversos ligados a la hospitalización, ENEAS 2005]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Madrid, España ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Sanidad y Consumo]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kohn]]></surname>
<given-names><![CDATA[L.T.]]></given-names>
</name>
<name>
<surname><![CDATA[Corrigan]]></surname>
<given-names><![CDATA[J.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Donaldson]]></surname>
<given-names><![CDATA[M.S.]]></given-names>
</name>
</person-group>
<source><![CDATA[To err is human: building a safer health system]]></source>
<year>2000</year>
<publisher-loc><![CDATA[National Academies Press, Washington D.C ]]></publisher-loc>
<publisher-name><![CDATA[Institute of Medicine (US) Committee on Quality of Health Care in America]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Alianza mundial para la seguridad del paciente: la investigación en seguridad del paciente]]></source>
<year>2008</year>
<publisher-loc><![CDATA[París ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<collab>Ministerio de Salud y Protección Social</collab>
<source><![CDATA[Seguridad del paciente y la atención segura]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>Ministerio de Salud y Protección Social</collab>
<source><![CDATA[Sistema único de acreditación Bogotá (Colombia)]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aranaz]]></surname>
<given-names><![CDATA[A.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Aibar]]></surname>
<given-names><![CDATA[R.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Limón-Ramírez]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Amarilla]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Restrepo]]></surname>
<given-names><![CDATA[F.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Urroz]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of adverse events in the hospitals of five Latin American countries: Results of the 'Iberoamerican study of adverse events' (IBEAS)]]></article-title>
<source><![CDATA[BMJ Qual. Saf]]></source>
<year>2011</year>
<volume>20</volume>
<numero>1043</numero>
<issue>1043</issue>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rico]]></surname>
<given-names><![CDATA[J. Velasco-]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neoliberalismo, salud pública y atención primaria: las contradicciones en el paradigma de salud para todos]]></article-title>
<source><![CDATA[ColombiaMed]]></source>
<year>1997</year>
<volume>28</volume>
<numero>27</numero>
<issue>27</issue>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menéndez]]></surname>
<given-names><![CDATA[E.L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Modelo médico hegemónico: reproducción técnica y cultural]]></article-title>
<source><![CDATA[Natura Medicatrix]]></source>
<year>1998</year>
<volume>51</volume>
<numero>17</numero>
<issue>17</issue>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Peddie]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wickham]]></surname>
<given-names><![CDATA[M.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Badke]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Small]]></surname>
<given-names><![CDATA[S.S.]]></given-names>
</name>
<name>
<surname><![CDATA[Doyle]]></surname>
<given-names><![CDATA[M.M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adverse drug event reporting systems: A systematic review]]></article-title>
<source><![CDATA[Br. J. Clin. Pharmacol]]></source>
<year>2016</year>
<volume>82</volume>
<numero>17</numero>
<issue>17</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Marco conceptual de la clasificación internacional para la seguridad del paciente]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[The WHO programme for international drug monitoring]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Uppsala ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<collab>ATC/DDD</collab>
<source><![CDATA[Index 2014 Norwegian, WHO Collaborating Centre for Drug Statistics Methodology]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<collab>Ministerio de Sanidad, Política Social e Igualdad</collab>
<source><![CDATA[Incidentes y eventos adversos en medicina intensiva. Seguridad y riesgo en el enfermo crítico. SYREC 2007]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Ministerio de Sanidad, Política Social e Igualdad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado-Alba]]></surname>
<given-names><![CDATA[J.E]]></given-names>
</name>
<name>
<surname><![CDATA[Giraldo-Giraldo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Moncada-Escobar]]></surname>
<given-names><![CDATA[J.C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Farmacovigilancia activa en pacientes afiliados al sistema general de seguridad social en salud]]></article-title>
<source><![CDATA[Rev. Salud Pública]]></source>
<year>2010</year>
<volume>12</volume>
<numero>580</numero>
<issue>580</issue>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado-Alba]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Londoño-Builes]]></surname>
<given-names><![CDATA[M.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Echeverri-Cataño]]></surname>
<given-names><![CDATA[L.F.]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa-Orozco]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2016</year>
<volume>36</volume>
<numero>59</numero>
<issue>59</issue>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado-Alba]]></surname>
<given-names><![CDATA[J.E.]]></given-names>
</name>
<name>
<surname><![CDATA[Moncada]]></surname>
<given-names><![CDATA[J.C.]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno-Gutiérrez]]></surname>
<given-names><![CDATA[P.A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication errors in outpatient care in Colombia, 2005-2013]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2016</year>
<volume>36</volume>
<numero>251</numero>
<issue>251</issue>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Napal]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrándiz]]></surname>
<given-names><![CDATA[J.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dispensación con intervención previa del farmacéutico: dosis unitarias]]></article-title>
<source><![CDATA[Farmacia hospitalaria]]></source>
<year>2002</year>
<volume>I</volume>
<page-range>389-414</page-range><publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Sociedad Española de Farmacia Hospitalaria]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castro-Espinosa]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frecuencia y caracterización de los errores de medicación en un servicio de hospitalización de una clínica en Cali, Colombia]]></article-title>
<source><![CDATA[Rev. Colomb. Cienc. Quim. Farm]]></source>
<year>2013</year>
<volume>42</volume>
<numero>5</numero>
<issue>5</issue>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elliott]]></surname>
<given-names><![CDATA[R.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Jankovic]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[M.M. St]]></given-names>
</name>
<name>
<surname><![CDATA[Kaltenthaler]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Prevalence and economic burden of medication errors in the NHS in England]]></source>
<year>2018</year>
<publisher-name><![CDATA[Manchester Centre for Health Economics, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, University of Manchester]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Varallo]]></surname>
<given-names><![CDATA[F.R.]]></given-names>
</name>
<name>
<surname><![CDATA[Guimaraes]]></surname>
<given-names><![CDATA[S.O.]]></given-names>
</name>
<name>
<surname><![CDATA[Abjaude]]></surname>
<given-names><![CDATA[S.A.]]></given-names>
</name>
<name>
<surname><![CDATA[Mastroianni]]></surname>
<given-names><![CDATA[P.C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Causes for the underreporting of adverse drug events by health professionals: A systematic review]]></article-title>
<source><![CDATA[Rev. Esc. Enferm. USP]]></source>
<year>2014</year>
<volume>48</volume>
<numero>739</numero>
<issue>739</issue>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="book">
<collab>Pharmacovigilance Risk Assessment Committee</collab>
<source><![CDATA[Good practice guide on recording, coding, reporting and assessment of medication errors]]></source>
<year>2015</year>
<publisher-name><![CDATA[European Medicines Agency]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[I.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A new Erice report considering the safety of medicines in the 21st century]]></article-title>
<source><![CDATA[DrugSaf]]></source>
<year>2017</year>
<volume>40</volume>
<numero>845</numero>
<issue>845</issue>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moscoso-Veloza]]></surname>
<given-names><![CDATA[S.M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ramírez-Cubillos]]></surname>
<given-names><![CDATA[G.F.]]></given-names>
</name>
<name>
<surname><![CDATA[López-Gutiérrez]]></surname>
<given-names><![CDATA[J.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Gerena-Useche]]></surname>
<given-names><![CDATA[B.E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reacciones adversas a medicamentos en el Hospital de Suba de Bogotá]]></article-title>
<source><![CDATA[Rev. Salud Pública]]></source>
<year>2006</year>
<volume>8</volume>
<numero>209</numero>
<issue>209</issue>
</nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chaves]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de reacciones adversas a medicamentos en adultos mayores de 44 años en Bogotá, D.C., enero a diciembre, 2012]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2015</year>
<volume>35</volume>
<numero>34</numero>
<issue>34</issue>
</nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de las Salas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Agudelo]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Burgos-Flórez]]></surname>
<given-names><![CDATA[F.J.]]></given-names>
</name>
<name>
<surname><![CDATA[Vaca]]></surname>
<given-names><![CDATA[C.P.]]></given-names>
</name>
<name>
<surname><![CDATA[Serrano-Meriño]]></surname>
<given-names><![CDATA[D.V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adverse drug reactions in hospitalized Colombian children]]></article-title>
<source><![CDATA[Colombia Méd]]></source>
<year>2016</year>
<volume>47</volume>
<numero>142</numero>
<issue>142</issue>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="book">
<collab>WHO</collab>
<source><![CDATA[Reporting and learning systems for medication errors: the role of pharmaco-vigilance centres]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Geneve, Switzerland ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orozco]]></surname>
<given-names><![CDATA[J.G.]]></given-names>
</name>
</person-group>
<source><![CDATA[De la farmacovigilancia al monitoreo crítico de los medicamentos. El proceso de registro de medicamentos en Colombia]]></source>
<year>2012</year>
<page-range>50-80</page-range><publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Nacional de Colombia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De-Abajo]]></surname>
<given-names><![CDATA[F.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El medicamento como solución y como problema para la salud pública. Una breve incursión a los objetivos de la farmacoepidemiología]]></article-title>
<source><![CDATA[Rev. Esp. Salud Pública]]></source>
<year>2001</year>
<volume>75</volume>
<numero>281</numero>
<issue>281</issue>
</nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Laporte]]></surname>
<given-names><![CDATA[J.R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fifty years of pharmacovigilance. Medicines safety and public health]]></article-title>
<source><![CDATA[Pharmacoepidemiol. Drug Saf]]></source>
<year>2016</year>
<volume>25</volume>
<numero>725</numero>
<issue>725</issue>
</nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Caster]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[R.I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reflections on attribution and decisions in pharmaco-vigilance]]></article-title>
<source><![CDATA[Drug Saf]]></source>
<year>2010</year>
<volume>33</volume>
<numero>805</numero>
<issue>805</issue>
</nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[R.I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Causality Assessment in Pharmacovigilance: Still a Challenge]]></article-title>
<source><![CDATA[DrugSaf]]></source>
<year>2017</year>
<volume>40</volume>
<numero>365</numero>
<issue>365</issue>
</nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gervas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[El fracaso programado de la farmacovigilancia. Apropósito del «escándalo Depakine»: Hay culpables y no son los médicos, No Gracias: Organización Civil Internacional (España, Argentina, Uruguay) por la transparencia, la integridad y la equidad en las políticas de salud, la asistencia sanitaria y la investigación biomédica]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Price]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacovigilance in crisis: Drug safety at a crossroads]]></article-title>
<source><![CDATA[Clin. Ther]]></source>
<year>2018</year>
<volume>S0149-2918</volume>
<numero>30088</numero>
<issue>30088</issue>
</nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morin]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epistemología de la complejidad]]></article-title>
<source><![CDATA[Gazeta de Antropología]]></source>
<year>2004</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ugalde]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Homedes]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Las reformas neoliberales del sector de la salud: déficit gerencial y alienación del recurso humano en América Latina]]></article-title>
<source><![CDATA[Rev. Panam. Salud Pública]]></source>
<year>2005</year>
<volume>17</volume>
<numero>202</numero>
<issue>202</issue>
</nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Illich]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Némesis médica: La expropiación de la salud]]></source>
<year>1975</year>
<page-range>218</page-range><publisher-loc><![CDATA[España ]]></publisher-loc>
<publisher-name><![CDATA[Barral editores]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
